GobyMeds at a glance
| Type | Telehealth + 503A pharmacy partner |
| Medications | Compounded semaglutide, compounded tirzepatide |
| Initial consult | Free |
| Monthly pricing | Competitive with peers (mid-market) |
| State coverage | Most US states |
| Insurance | Cash-pay (HSA/FSA eligible) |
| Editor ranking | Editor's Pick #1 (Best for Compounded) |
| Best for | Cash-pay patients who want zero-cost intake before committing |
Why we picked GobyMeds as Editor's Pick #1
We maintain a live editor-ranked list of compounded-GLP-1 telehealth providers based on reader feedback, transparent pricing, clinician responsiveness, and pharmacy partner verification. GobyMeds currently sits in slot #1 for “Best for Compounded” on three grounds:
- Free initial consultation — lowers the entry barrier vs $40–$100 intake fees charged by some peers. Lets patients confirm eligibility before committing.
- Transparent pricing — monthly costs visible on the website before signup. No hidden discovery calls or pressure-tactic pricing.
- Reader feedback — our portfolio editorial team aggregates user feedback across reviews; GobyMeds consistently scores well on clinician responsiveness and shipping reliability.
What the free consult actually includes
The GobyMeds free consultation covers:
- Medical questionnaire (typically 8–12 minutes online)
- BMI verification and weight history
- Comorbidity and contraindication screening
- Licensed clinician review of your intake (24–72 hours)
- Eligibility determination — you'll know whether you qualify before paying anything
If you're cleared and choose to fill: monthly medication cost applies, billed to a card on file. If you decline to fill, you owe nothing. This intake model is meaningfully more patient-friendly than “pay $80 to find out if you qualify.”
Legitimacy
The legitimacy bar for compounded-GLP-1 telehealth: (1) state-licensed 503A pharmacy partners, (2) US-licensed clinicians, (3) medication shipped from the US. GobyMeds meets all three. They publish their pharmacy partner state-board licensure info after intake and operate within the established US telehealth + 503A framework.
What that doesn't mean: it doesn't mean compounded GLP-1 is FDA-approved (it's not — that's true of every compounded program). It doesn't mean the medication has been through clinical trials separate from the brand-name molecule (it hasn't — compounded versions are bioequivalent in active ingredient but don't have separate trial data). It means GobyMeds operates legally within the existing US regulatory framework for compounded medications.
Pricing context
We don't republish specific dose-tier pricing in editorial content (FDA enforcement action in 2026 clarified that dose-tier pricing republishing carries drug-misbranding risk for editorial sites). Current pricing is published transparently on the GobyMeds website. The pricing tier sits in the mid-market for compounded-GLP-1 telehealth — comparable to Brightmeds, slightly above Direct Meds' lowest-tier compounded tirzepatide rate, generally below Mochi Health's bundled-support pricing.
Who GobyMeds is right for
- Cash-pay patients with BMI eligibility who want to confirm eligibility before paying.
- Patients without insurance coverage for brand-name Zepbound or Wegovy.
- Patients on Medicarewho can't use the manufacturer savings card.
- Patients who want both semaglutide AND tirzepatide options available within the same provider (some providers carry only one).
- First-time telehealth-GLP-1 patients who want a low-friction entry point.
Who GobyMeds isn't right for
- Patients with commercial insurance that covers brand-name GLP-1 at $25/month savings card — the savings card is dramatically cheaper than any compounded program.
- Patients who want brand-name Zepbound or Wegovy specifically — that requires Lilly or Novo's direct programs (LillyDirect $399 / NovoCare $499) or retail pharmacy.
- Patients with clinical exclusions — personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, severe pancreatitis history, active eating disorder, pregnancy or planned pregnancy within 2 months, Type 1 diabetes. These exclusions apply to every GLP-1 program.
- Patients in states with restricted compounded-GLP-1 availability — check at intake.
Alternative providers to compare
Telehealth-GLP-1 is competitive and switching costs are low. Worth comparing on your specific state and dose preference:
Frequently asked questions
Is GobyMeds legit?
Yes — GobyMeds is a US telehealth provider connecting patients with state-licensed clinicians and 503A compounding pharmacies for compounded semaglutide and tirzepatide. They operate under the standard telehealth-prescribing framework used by Brightmeds, Henry Meds, and similar peers. Verify the specific pharmacy ships to your state during signup; this applies to every compounded-GLP-1 provider.
Does GobyMeds actually offer a free consultation?
Yes — the initial intake consultation is free, with no charge for the intake questionnaire or clinician review. If you're prescribed and choose to fill, monthly medication cost applies. The free-initial-consult model lowers the entry barrier compared to providers that charge a $40–$100 intake fee, and it lets you confirm eligibility before committing to a monthly subscription.
What does GobyMeds cost?
GobyMeds publishes monthly pricing for compounded semaglutide and tirzepatide that's competitive with the broader compounded-GLP-1 market ($150–$250/month depending on dose and program tier). The first consultation is free; you only pay if you fill the prescription. Specific current rates are visible on the GobyMeds website after the free intake. We don't republish dose-tier pricing in editorial content per FDA enforcement guidance.
GobyMeds vs Brightmeds — which is better?
Both rank in our top tier for compounded-GLP-1 telehealth in 2026. GobyMeds has the free-consult advantage at intake. Brightmeds has a slightly cleaner monthly subscription structure. Pricing is comparable. For most patients, the deciding factors are (a) which one ships to your state, and (b) which clinician network you prefer once you're past the first consult.
What states does GobyMeds ship to?
GobyMeds covers most US states. Telehealth-GLP-1 access varies state-by-state based on (a) the pharmacy partner's state board licensure and (b) the prescribing clinician's state license. Mississippi, Louisiana, and Alabama have historically had the most variable access. Enter your state in the GobyMeds intake to confirm before completing the questionnaire.
Is the medication FDA-approved?
No — compounded GLP-1 medications are not FDA-approved. They're individually compounded preparations from 503A pharmacies under specific FDA conditions that permit compounding when a patient has a valid prescription. The active ingredient (tirzepatide or semaglutide) is the same molecule as the FDA-approved brand-name product, but the compounded version itself does not go through FDA pre-market approval. This is true of every compounded GLP-1 telehealth provider.
Will my insurance cover GobyMeds?
No — compounded GLP-1 programs through telehealth providers are cash-pay only. Insurance coverage for GLP-1s requires FDA-approved brand-name products and an in-network prescriber. Compounded medications are outside the insurance reimbursement framework. HSA and FSA funds can typically be applied — check with your benefits administrator. If you have commercial insurance that covers Zepbound or Wegovy, the manufacturer savings card ($25/month) is significantly cheaper than any compounded program.
How fast does GobyMeds ship?
After clinician approval (typically 24–72 hours from intake completion), medication ships within 3–7 business days. Refill shipping for established patients is usually 1–3 business days from the auto-refill date. Track shipment status in the patient portal.
Can I switch to GobyMeds from another provider?
Yes — telehealth GLP-1 providers handle prescription transfers routinely. Either provide your current prescription details during GobyMeds intake, or restart fresh with a new GobyMeds clinician evaluation. Most patients who switch are doing so for pricing, faster shipping, or better clinician responsiveness — telehealth-GLP-1 has low switching costs, which is part of why pricing is competitive.
Editor's verdict
GobyMeds is our Editor's Pick #1 for compounded-GLP-1 telehealth in 2026. The free initial consult is a genuine differentiator vs peers that charge $40–$100 to even check eligibility. State-licensed 503A pharmacy partners, US clinician network, transparent pricing, broad state coverage. Right fit for cash-pay patients without insurance coverage for brand-name GLP-1. If you have commercial insurance that covers Zepbound or Wegovy at $25/month, take that path. If not, start with GobyMeds' free intake.